‘We’re not there yet’: Biden officials issue somber warning about uptick in Covid-19 cases
WASHINGTON — Biden administration officials on Friday warned of a “very concerning” uptick in Covid-19…
Category: Medicine
Opinion: Sen. Rand Paul misunderstands transgender medicine. Here’s the truth
In a tense exchange on Thursday during the Senate confirmation hearing of Dr. Rachel Levine,…
STAT+: Pharmalittle: Sarepta wins another FDA nod; Germans balk at AstraZeneca vaccine
Good morning, one and all. Damian Garde here, filling in for Ed Silverman in the…
.jpg)
Tracking an FDA advisory panel’s meeting on J&J’s Covid-19 vaccine
Now it’s Johnson & Johnson’s turn. A panel of outside experts is meeting Friday for…
STAT+: Sen. Cassidy explains why he’s backing a bill aimed at drug-resistant bacteria
The Covid-19 pandemic has shown the damage that an uncontrolled infectious disease can cause society….
Here are the contenders for STAT Madness 2021. Voting begins Monday
For science, 2020 was a year like no other, as labs around the world shifted…
Opinion: Primary care practices could be the Biden administration’s secret weapon in the fight against Covid-19
For a small-town physician, being given a supply of the Covid-19 vaccine can make a…
Andrew Cuomo’s Covid-19 nursing home fiasco shows the ethical perils of pandemic policymaking
WASHINGTON — The humbling of New York Gov. Andrew Cuomo on pandemic policy has been…
After allegations of racism and sexism, some applicants remove Tulane from residency rankings
With time running out for their medical residency decisions, some applicants say they’re taking Tulane…
Words from the Wise about Covid and the Heart
Covid-19 is having a surprising effect on the heart and vascular system. We spoke to…
STAT+: The vial is not half empty: New report lays out ways to address the issue of discarded drugs
File this under ‘Waste not, want not.’ In response to the cost of medicines, a…
Listen: Covid vaccines for teens, Novavax’s remarkable rise, and the future of HHS
Why can’t kids get Covid-19 vaccines? Is there hope for biotech penny stocks? And when…
Sarepta wins new drug approval for patients with Duchenne muscular dystrophy, its third marketed treatment
The Food and Drug Administration on Thursday approved a new medicine from Sarepta Therapeutics that…
Companies Pan for Marketing Gold in Vaccines
“They mentioned it like it was an amenity, like ‘We have a swimming pool and…
Opinion: Discarded drugs: a wasteful and costly problem that requires whole-of-government approaches
Controlling the rising costs of pharmaceuticals, particularly those administered by physicians, has been a top…
Virtual Event: The pandemic’s toll on mental health
Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET. …
Why using fear to promote COVID-19 vaccination and mask wearing could backfire
You probably still remember public service ads that scared you. With new, highly transmissible variants…
STAT+: Pharmalittle: Moderna proceeds with a vaccine trial to combat Covid-19 variant; who will be the next FDA commish?
Top of the morning to you, and a fine one it is. Once again, clear…
STAT+: A U.S. court ruling may force biologics makers to review patent protections
In a decision with broad implications for the pharmaceutical industry, a U.S. appeals court recently…
STAT+: CytoDyn has data on its highly touted experimental Covid treatment. Investors and patients don’t
CytoDyn CEO Nader Pourhassan has been uncharacteristically quiet this week about a completed clinical trial…
GlaxoSmithKline Covid-19 drug falls short in trial, but may benefit older patients
An experimental rheumatoid arthritis drug being developed by GlaxoSmithKline failed to show a significant benefit…
Is more simply better? Why Pfizer thinks a booster of its Covid vaccine might work against new variants
Could the solution to emerging variants of the coronavirus that causes Covid-19, some of which…
Opinion: CDC estimated a one-year decline in life expectancy in 2020. Not so — try five days
The Centers for Disease Control and Prevention made headlines last week when it announced that…
‘We need to get in the room’: Hospital chaplains struggle to balance Covid safety with patients’ spiritual needs
Infection fears have never slowed down Rev. Moneka Thompson. For more than 10 years, she’s…
‘A full court press’: Banking on tech backup, CDC launches nationwide VaccineFinder tool
On Wednesday, federal officials quietly opened up access to VaccineFinder, a site that allows the…
Challenging the link between statins and muscle pain, patients report no difference in aches when taking drug or placebo
Statins — among the most successful drugs ever developed — prevent deaths from heart attacks…
This Trial Allows for Medical Abortion Via the Mail
In December, the Supreme Court reversed a lower court ruling that had allowed abortion medications…
Pfizer-BioNTech vaccine performs as well in the real world as in clinical trials, new study concludes
Pfizer and BioNTech’s Covid-19 vaccine performed as well in the real world as it did…
.jpg)
Moderna ready to test version of Covid-19 vaccine aimed at worrisome variant
Moderna is pressing forward with a modified version of its Covid-19 vaccine meant to protect…
STAT+: Once again, the credit outlook for the pharmaceutical industry is negative
For the eighth consecutive year, the credit outlook for the pharmaceutical industry is negative and…
One month in, how Biden has changed disaster management and the US COVID-19 response
After one month in office, the Biden administration has fundamentally changed how the federal government…
Opinion: Listen: Catherine Mezzacappa and Ruth Faden on vaccinations and pregnancy
This week on “The First Opinion Podcast,” I talk with Catherine Mezzacappa and Ruth Faden…
STAT+: ‘It looks like a spaghetti bowl’: Scientists reveal a precise structure in a fabled worm’s tangled brain
Using Facebook-like algorithms, a bespoke microscope, and hefty doses of patience, a team of scientists…
STAT+: Pharmalittle: FDA scientists say J&J Covid-19 shot is effective; vaccine makers predict big jump in deliveries this month
Good morning, everyone, and how are you today? We are doing just fine, thanks to…
New data shed light on efficacy of J&J’s single-dose vaccine against Covid-19
Scientists at the Food and Drug Administration said Wednesday that the single-shot Covid-19 vaccine developed…
STAT+: With genome-editing companies’ stock booming, Beam Therapeutics seizes its moment
Beam Therapeutics, a company focused on genome editing, is in a strange situation. The firm’s…
Opinion: Three steps can help companies speed FDA approval of new drugs
Drug developers see Food and Drug Administration approval as a difficult uphill climb, requiring large…
Opinion: Vaccine equity: If we build it, will they come?
In partnership with the federal government, California launched two massive Covid-19 vaccination sites this week….
How Covid-19 could usher in a new role for continuous glucose monitoring in hospitals
In early May, a wing of Ohio State University’s Wexner Medical Center was eerily empty….
Backed by Google, epidemiologists launch a sweeping Covid-19 data platform
Last January, Samuel Scarpino wasn’t sure what to make of Covid-19. The director of Northeastern…
The Do’s and Don’ts on Social Media for Vaccine Haves and Have-Nots
In the thick of a global pandemic, and with the shaky rollout of covid vaccines…
Despite Pot’s Increasing Legitimacy, Acceptance is Anything but Consistent
15 states have legalized recreational marijuana, but in some places, it is still slow going….
STAT+: OpenBiome to wind down stool bank operations
OpenBiome, the nation’s first public stool bank, will soon end its program for collecting, screening,…
A Few Steps Forward, One or Two Back: Covid in the USA
A year into the coronavirus pandemic, life in America remains almost unrecognizable. How long will…
STAT+: Republicans’ surprising Becerra attack: He’s not sympathetic enough to pharma
WASHINGTON — Republican senators on Tuesday blasted President Biden’s health secretary nominee using an unexpected…
STAT+: Access to heart drugs improves in middle-income countries, but still lags compared to wealthy nations
Middle-income countries have gained greater access to a variety of needed cardiovascular medicines, but remain…
STAT+: STAT+ Conversations: A conversation with a leading biotech venture capitalist
Editors Note: A livestream of the conversation will be embedded below at 1 p.m. ET….
STAT+: Pharmalittle: Pfizer accused of ‘bullying’ some countries during vaccine talks; FDA to quickly analyze Covid-19 booster shots
Rise and shine, everyone, another busy day is on the way. This morning is getting…
STAT+: Google reveals new progress on controversial project using patient data
More than a year after facing widespread criticism over its patient data-sharing arrangement with hospital…
Dozens of institutional investors push for ‘fair and equitable’ Covid-19 response
Nearly 150 institutional investors that oversee combined assets worth more than $14 trillion have issued…